Solid lipid nanoparticles (SLN) as potential carrier for human use: Interaction with human granulocytes

Journal of Controlled Release

Volumn 47, Issue 3, 1997, Pages 261-269

  Muller R H ^a   Maassen, S ^b   Schwarz, C ^a   Mehnert, W ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytotoxicity; Phagocytosis; Poloxamer; SLN; Solid lipid nanoparticles

Indexed keywords

DRUG CARRIER; GLYCEROL BEHENATE; GLYCEROL DERIVATIVE; NANOPARTICLE; POLOXAMER; POLYGLACTIN; POLYSTYRENE; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CHEMOLUMINESCENCE; CIRCULATION TIME; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG MANUFACTURE; DRUG TARGETING; GRANULOCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; SPECTROSCOPY; SUSPENSION;

EID: 0342762031     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)01653-2     Document Type: Article

References (33)

1. R. Voigt, Pharmazeutische Technologie für Studium und Beruf, 7th edn., Ullstein Mosby, 1993.
2. T. Eldem, P. Speiser, and H. Altdorfer, Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry. Pharm. Res. 8 (1991) 178-184.
3. T. Eldem, P. Speiser, and A. Hincal, Optimization of spray-dried and -congealed lipid micropellets and characterization of their surface by scanning electron microscopy. Pharm Res. 8 (1991) 47-54.
4. R.H. Müller and J.S. Lucks, Arzneistoffträger aus festen Lipidteilchen - Feste Lipid Nanosphären (SLN). European Patent EP O 605 497 B1, 1991.
5. C. Schwarz, W. Mehnert, J.S. Lucks and R.H. Müller, Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization. J. Control. Release 30 (1994) 83-96.
6. P. Speiser, Lipidnanopellets als Trägersystem für Arzneimittel zur peroralen Anwendung. European Patent EP 0167825, 1990.
7. R.H. Müller, C. Schwarz, W. Mehnert and J.S. Lucks, Production of solid lipid nanoparticles (SLN) for controlled drug delivery, Proceedings of an International Symposium on Controlled Release and Bioactive Materials, No. 20, 1993, pp. 480-481.
8. R.M. Gasco, S. Morel and R. Carpignano, Optimization of deoxycorticosterone acetate in lipospheres. Eur. J. Pharm. Biopharm. 38(1) (1992) 7-10.
9. L. Boltri, T. Canal, P.A. Esposito and F. Carli, Lipid nanoparticles: Evaluation of some critical formulation parameters, I. Proceedings of an International Symposium on Controlled Release and Bioactive Materials, No. 20, 1993, pp. 346-347.
10. A.J. Domb, Liposphere parenteral delivery system. Proceedings of an International Symposium on Controlled Release and Bioactive Materials, No. 20, 1993, pp. 121-122.
11. K. Westesen, Development and characterization of novel intravenous emulsion system. Arch. Pharm. 324 (1991) 639.
12. K. Westesen and T. Wehler, Physicochemical characterization of a model intravenous oil in water emulsion. J. Pharm. Sci. 81 (1992) 777-786.
13. A. zur Mühlen, W. Mehnert, Drug incorporation and delivery of Prednisolone loaded solid lipid nanoparticles. Proceedings of the 1st World Meeting APGI/APV, Budapest 1995, p. 455.
14. R. Jeppson and S. Rössner, The influence of emulsifying agents and of lipid soluble drugs on the fractional removal rate of lipid emulsions from the blood stream of the rabbit. Acta Pharmacol. Toxicol. 37 (1975) 134-144.
15. L. Illum, L.O. Jacobsen, R.H. Müller, E. Mak and S.S. Davis, Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages. Biomaterials 8 (1987) 113.
16. S. Rudt, and R.H. Müller, In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake. J. Control. Release 25 (1993) 51-59.
17. S. Rudt and R.H. Müller, In vitro phagocytosis assay of nano- and microparticles by chemiluminescence. III. Uptake of differently sized surface-modified particles, and its correlation to particle properties and in vivo distribution. Eur. J. Pharm. Sci. 1 (1993) 31-39.
18. R.J. Hunter, Zeta Potential in Colloid Science: Principles and Applications, Academic Press, London, 1983.
19. S. Rudt and R.H. Müller, In vitro phagocytosis assay of nano and microparticles by chemiluminescence. I. Effect of analytical parameters, particle size and particle concentration. J. Control. Release 22 (1992) 263-272.
20. S. Rudt and R.H. Müller, In vitro uptake of polystyrene latex particles and parenteral fat emulsions by human granulocytes. Int. J. Pharm. 99 (1993) 1-6.
21. T. Mosmann, Rapic colorimetric assay of cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63.
22. van Oss, C.J., Gillman, C.F., Neumann, A.W., Phagocytic Engulfment and Cell Adhesiveness as Cellular Surface Phenomena, Marcel Dekker, New York, 1975.
23. R.H. Müller and T. Blunk, Properties of poloxamer and poloxamine coating layers on different sized polystyrene model drug carriers. Arch. Pharm. 322 (1989) 699.
24. R.H. Müller, Colloidal carriers for controlled drug delivery and targeting, Wissenschaftliche Verlagsgesellschaft Stuttgart, CRC Press, Boca Raton, FL, 1991.
25. J.H. Lee, and J.D. Andrade, Surface properties of aqueous PEO/PPO block copolymer surfactants. In: J.D. Andrade (Ed.), Polymer Surface Dynamics Plenum Press, New York 1989, pp. 119-136.
26. M.C. Davies, F. Koosha, and R.H. Müller, The surface analysis of micro- and nanoparticles by SSIMS. Acta Pharm. Technol. 34 (1988) 21S.
27. F. Koosha, R.H. Müller, S.S. Davis and M.C. Davies, The surface chemical structure of poly(β-hydroxybutyrate) microparticles produced by solvent evaporation process. J. Control. Release 9 (1989) 149-157.
28. J.B. Kayes and D.A. Rawlins, Absorption characteristics of certain polyoxyethylene-polyoxypropylene block copolymers and polystyrene latex. Colloid Polymer Sci. 257 (1979) 622-629.
29. H. Weyhers, W. Mehnert, J. Kreuter and R.H. Müller, Radiolabelling of Solid Lipid Nanoparticles (SLN). Eur. J. Pharm. Biopharm. 42 (1996) 42S.
30. H. Weyhers, Feste Lipid Nanopartikel (SLN) für die gewebsspezifische Arzneistoffapplikation - Herstellung und Charakterisierung oberflächenmodifizierter Formulierungen, PhD thesis, University of Berlin, 1995.
31. C. Lherm, R.H. Müller, F. Puisieux and P. Couvreur, Alkylcyanoacrylate drug carriers. II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int. J. Pharm. 84 (1992) 13-22.
32. S. Maaßen, C. Schwarz, W. Mehnert, J.S. Lucks, F. Yunis-Specht, B.W. Müller and R.H. Müller, Comparison of cytotoxicity between polyester nanoparticles and solid lipid nanoparticles (SLN), Proceedings of an International Symposium on Controlled Release and Bioactive Materials, No. 20, 1993, pp. 490-491.
33. H. Weyhers, S. Ehlers, W. Mehnert, H. Hahn, R.H. Müller, Solid lipid nanoparticles - determination of in vivo toxicity, Proceedings of the 1st World Meeting APGI/APV, Budapest, 1995, pp. 489-490.